SAMANTHA MRAZ: Open Payments
NPI 1013484088 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46,287 in 118 payments from 11 companies in 2025. Trend: 2023 $15,383 · 2024 $24,286 · 2025 $46,287
Speaker / faculty: $32,378Consulting: $6,000Travel & lodging: $4,823Food & beverage: $3,086
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 60 | $39,586 |
| ABBVIE INC. | 14 | $5,607 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $323 |
| Alkermes, Inc. | 8 | $223 |
| E.R. Squibb & Sons, L.L.C. | 12 | $216 |
| Teva Pharmaceuticals USA, Inc. | 6 | $133 |
| Vanda Pharmaceuticals Inc. | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, COBENFY, LYBALVI, FANAPT, ARISTADA, AUSTEDO XR.
Industry payments across CT — which companies pay providers there.
